Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Consolidated net loss	$ (719,562)	$ (833,597)
Adjustments to reconcile net loss including noncontrolling interest to net cash and cash equivalents provided by operations:
Depreciation and amortization expense	175,126	153,611
Stock-based compensation expense	757,558	617,288
Operating lease non-cash expense	88,592	70,801
(Accretion)/amortization on marketable securities, net	(60,442)	(52,219)
Amortization of debt issuance costs	1,023	982
Impairment expense, (gain)/loss on investment and other asset sales, and other, net	2,350	7,747
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	119,460	93,174
Prepaid expenses and other current assets	3,340	(1,861)
Deferred cost of revenue	(99,491)	(62,074)
Other assets	(4,922)	(6,189)
Accounts payable	(4,404)	3,855
Accrued expenses and other current liabilities	(15,278)	(2,599)
Developer exchange liability	15,405	7,724
Deferred revenue	409,809	360,098
Operating lease liabilities	(54,621)	(46,837)
Other long-term liabilities	23,882	4,971
Net cash and cash equivalents provided by operating activities	637,825	314,875
Cash flows from investing activities:
Acquisition of property and equipment	(115,786)	(255,470)
Payments related to business combination, net of cash acquired	(2,840)	(3,859)
Purchases of intangible assets	(1,370)	(13,500)
Purchases of investments	(3,474,187)	(3,803,911)
Maturities of investments	2,431,770	956,010
Sales of investments	394,853	346,766
Net cash and cash equivalents used in investing activities	(767,560)	(2,773,964)
Cash flows from financing activities:
Proceeds from issuance of common stock	57,196	47,316
Proceeds from debt issuances	0	14,700
Financing payments related to acquisitions	(4,450)	(750)
Net cash and cash equivalents provided by financing activities	52,746	61,266
Effect of exchange rate changes on cash and cash equivalents	1,154	398
Net increase/(decrease) in cash and cash equivalents	(75,835)	(2,397,425)
Cash and cash equivalents
Beginning of period	678,466	2,977,474
End of period	602,631	580,049
Supplemental disclosure of noncash investing and financing activities:
Property and equipment additions in accounts payable and accrued expenses and other liabilities	$ 23,255	$ 62,248